Simultaneous MAO-B and COMT inhibition i
โ
Dr. Jukka Lyytinen; Seppo Kaakkola; Sirpa Ahtila; Pรคivi Tuomainen; Heikki Terรคvรค
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 801 KB
## Abstract The effect of selegiline (Lโdeprenyl) on plasma catecholamines, clinical response, and drug tolerability was studied in 13 patients with Parkinson's disease (PD) treated with LโDopa/benserazide and entacapone, a peripheral catecholโ__O__โmethyltransferase (COMT) inhibitor, in a placeboโ